MyoStrain Enables Heart Failure Monitoring and Management

Directly measuring the impact of treatment on heart function

The Problem with Conventional Cardiac Monitoring and Treatment

Traditional measurements, like ejection fraction, do not measure subtle changes in heart function


 Strain can directly measure even small changes in heart function caused by disease or treatment

Graph Derived From Reference: [11]

MyoStrain Provides Quantitative
Feedback for Personalized Treatment

Measuring effects on heart function over time

Heart Failure Monitoring - Decision Feedback Loop with MyoStrain

Scale Reference: [08, 09, 10]

How MyoStrain Works

10 Minute Exam, 6 Heartbeat Scan, 37 Region Analysis,
1 Quantitative Diagnostic Report


2 Minutes

Technician positions patient in MRI.


5 Minutes

No patient breath-hold, contrast agent, or exposure to radiation required.


3 Minutes

Full report with global and regional strain metrics is generated and sent to the referring physician.

MyoStrain Provides Actionable Data Over Time

Empowering physicians to measure change and potentially make better treatment decisions

Baseline Report
Heart Failure Monitoring - MyoStrain Baseline Report
  1. Global Strain Measures:
    MyoStrain provides a global measure of heart strain, indicating heart function as a whole.
  1. Traditional Measures:
    MyoStrain provides traditional heart function metrics, including ejection fraction, mass, and volume.
  1. Weak Regional Strain:
    MyoStrain metrics indicate dysfunction, helping physicians make informed treatment decisions.
Improved Follow-Up Report
Heart Failure Monitoring - Follow-Up MyoStrain Report
  1. Change in Global Strain:
    In this case, the patient’s global strain indicates improved heart function after treatment.
  1. Consistency in Ejection Fraction:
    The patient’s ejection fraction did not show  significant change, meaning the physician cannot rely on ejection fraction to guide the patient’s therapy.
  1. Change in Regional Strain:
    MyoStrain helps monitor a patient’s response to drug therapy, showing regional improvement in the function of high-risk areas of the heart.
  1. Change in Diagrams:
    Diagrams show improvement of strain metrics trending towards healthier function after initiating treatment.

Contact Us

We work with Medical Research Centers, MRI Manufacturers, Outpatient Imaging Centers and Physicians

Myocardial Solutions' technology has been used globally in over 70 major medical research centers and is established as the gold standard for strain measurement. The research has yielded over 250 articles in peer-reviewed journals (50 articles from Circulation and JACC alone) that validate CMR strain testing. MyoStrain’s predecessor software (HARP & VIRTUE) have 510(k) clearance and CE Mark certification.
MyoStrain has CE mark certification, and Myocardial Solutions is actively pursuing FDA 510(k) clearance for MyoStrain.